<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">In 2017/18 influenza B predominance was reported in countries throughout the northern hemisphere. It was the leading influenza type in Europe and Canada 
 <xref rid="b0035" ref-type="bibr">[7]</xref>, 
 <xref rid="b0040" ref-type="bibr">[8]</xref>, 
 <xref rid="b0045" ref-type="bibr">[9]</xref> and the second most common type after influenza A/H3N2 in the USA 
 <xref rid="b0050" ref-type="bibr">[10]</xref>. In Germany, after the seasons of 2001/2, 2005/6 and 2015/16, it was only the fourth season of the 21st century with a dominance of influenza B 
 <xref rid="b0055" ref-type="bibr">[11]</xref>. As the prevailing lineage of influenza B changes frequently, the World Health Organization (WHO) recommended to include both lineages in a tetravalent vaccine in 2012 
 <xref rid="b0060" ref-type="bibr">[12]</xref>.
</p>
